The PML growth-suppressor has an altered expression in human oncogenesis
| Autor: | marcel koken, Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M. K., Sobczak-Thepot, J., Juhlin, L., Degos, L., Calvo, F., The, H. |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Tumor Suppressor Proteins
Cell Cycle Transplantation Heterologous Mice Nude Nuclear Proteins Estrogens In Vitro Techniques Promyelocytic Leukemia Protein Immunohistochemistry Growth Inhibitors Neoplasm Proteins Mice Neoplasms Tumor Cells Cultured Animals Humans Female Neoplasm Transplantation Skin Transcription Factors |
| Zdroj: | Europe PubMed Central Scopus-Elsevier |
| ISSN: | 0950-9232 |
| Popis: | Altered sub-nuclear localisation of the nuclear body-associated PML protein in acute promyelocytic leukaemia, has been proposed to contribute to leukaemogenesis. We have recently shown that PML is a primary target gene of interferons. Here, it is shown that PML has growth suppressive properties and displays an altered expression pattern during human oncogenesis. PML is widely expressed in cell-lines and is cell-cycle regulated. Overexpression of the protein induces a sharp reduction in growth rates in vitro and in vivo. In contrast with cell-lines, in normal tissues (including those that rapidly proliferate) only a few cells have detectable PML levels. However, these can be upregulated by soluble factors (e.g. IFN, estrogens). Human epithelial tumors show a gradual increase of PML levels as the lesion progresses from benign dysplasia to carcinoma. A similar induction is found in the surrounding stroma and vessels, which likely results from paracrine interactions. Strikingly, when malignant cells turn invasive, they loose PML expression, while expression is conserved in the stromal compartment. These observations point to the existence of a consistent deregulation in the expression of the PML growth-suppressor during human oncogenesis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|